Dr David Kerr on the latest setback from this once promising therapy.

Dr David Kerr on how one of the biggest studies at ASCO is already changing practice.

At ESMO 2017, Drs Zimmermann, Svane, and Coukos discuss successes and setbacks in immuno-oncology.

The risk for uterine sarcoma being found in fibroids is too high, notes Dr Markman.

Dr S. Vincent Rajkumar discusses the most promising new treatments reported for multiple stages of myeloma at this year's ASH meeting.

A case report suggests that IL-17 plays an important role in immune checkpoint inhibition, argues Dr David Kerr.

Dr JoAnn Manson offers clinicians a new resource to guide discussions with patients about vitamins and supplements.

Drs Perales and Pasquini discuss the rapidly advancing field of CAR T and how patient safety and choice can be managed during these unprecedented times.

Drs Kathy Miller and Reshma Jagsi on the reasons behind practitioners' reluctance to omit radiation therapy in older patients.

Dr John Marshall on how a recent symposium opened his eyes to the unintended effects of a bell-ringing ceremony at his practice.